Role of dendritic cells in the immune response against allografts

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 6, 2000, Pages 607-613

  Morelli, Adrian E ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ANTIGEN RECOGNITION; BONE MARROW CELL; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CHIMERA; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LYMPHOID CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY FORMATION; CHIMERA; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033693438     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200011000-00004     Document Type: Review

References (52)

1. Dendritic cells
2. Dendritic cells as regulators of immune reactivity: Implications for transplantation
3. Are dendritic cells the key to liver transplant tolerance?
4. Mobilizing dendritic cells for tolerance, priming and chronic inflammation
5. Direct and indirect recognition: The role of MHC antigens in graft rejection
6. Mapping of HLA-DR determinants recognized via the indirect pathway
7. Natural adjuvants: Endogenous activators of dendritic cells
8. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
9. Migration of dendritic cells to the draining lymph node after allogeneic or congeneic rat skin transplantation
10. The role of 'indirect' recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
11. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice
12. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice
13. Expression of B7 molecules in recipient, not donor mice determines the survival of cardiac allografts
14. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells
15. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells
16. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal
17. Blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells
18. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and BT-2)-positive dendritic cells
19. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells
20. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity
21. Freshly isolated Peyer's patch, but not spleen dendritic cells produce interleukin-10 and induce the differentiation of T helper type 2 cells
22. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo
23. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection
24. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
25. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
26. Reciprocal centrol of T helper cell and dendritic cell differentiation
27. Antigen-pulsed CD8 alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node
28. CTL priming by CD8(+) and CD8(-) dendritic cells in vivo
29. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
30. CD8alpha+ and CD8alphasubclasses of dendritic cells direct the development of distinct T helper cells in vivo
31. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1(dim), B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes
32. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival
33. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients
34. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation
35. Purified donor T cells alone activate transplantation immunity to the male antigen but induce tolerance in combination with MAC-1+ donor cells
36. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival
37. Prolonged skin allograft survival in mice treated with Flt3-ligand-induced dendritic cells and anti-CD154 monoclonal antibody
38. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb
39. Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin
40. Cyclosporine A inhibits the expression of costimulatory molecules on in-vitro-generated dendritic cells: Association with reduced nuclear translocation of nuclear factor kappa B
41. Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig)
42. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β
43. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in-vitro tolerogenicity and survival in allogeneic recipients
44. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness
45. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells
46. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
47. Cell migration, chimerism and graft acceptance
48. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance
49. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion
50. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat
51. Dendritic cells/chimerism/alleviation of chronic allograft rejection
52. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hematopoietic cells: Modulation by tacrolimus